bladder adenocarcinoma (Cancer)
Information
- Disease name
- bladder adenocarcinoma
- Disease ID
- DOID:3711
- Description
- "A bladder carcinoma that derives_from epithelial cells of glandular origin." [url:http\://en.wikipedia.org/wiki/Adenocarcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02834013 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | January 30, 2017 | May 1, 2026 |
| NCT03866382 | Recruiting | Phase 2 | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors | May 13, 2019 | February 28, 2025 |
| NCT05756569 | Recruiting | Phase 2 | Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology | September 26, 2023 | December 16, 2027 |
| NCT00072137 | Terminated | Phase 1 | Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy | October 2003 | November 2010 |
| NCT03912818 | Terminated | Phase 2 | Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer | April 10, 2019 | August 11, 2022 |
- Disase is a (Disease Ontology)
- DOID:4007
- Cross Reference ID (Disease Ontology)
- NCI:C4032
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:255110003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0279682
- Exact Synonym (Disease Ontology)
- adenocarcinoma of bladder
- Exact Synonym (Disease Ontology)
- adenocarcinoma of the urinary bladder
- Exact Synonym (Disease Ontology)
- bladder adenocarcinoma, Not Otherwise Specified